286 related articles for article (PubMed ID: 22467383)
1. Extracorporeal photopheresis: clinical use so far.
Sanford KW; Balogun RA
J Clin Apher; 2012; 27(3):126-31. PubMed ID: 22467383
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photopheresis: what is it and when should it be used?
Scarisbrick J
Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis: how, when, and why.
Ward DM
J Clin Apher; 2011; 26(5):276-85. PubMed ID: 21898572
[TBL] [Abstract][Full Text] [Related]
4. Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease.
Bisaccia E; Palangio M; Gonzalez J
Transfus Apher Sci; 2011 Oct; 45(2):187-90. PubMed ID: 21890415
[TBL] [Abstract][Full Text] [Related]
5. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal Photopheresis and Its Use in Clinical Dermatology in Canada.
Lagacé F; Netchiporouk E; Turchin I; Gulliver W; Dutz J; Kirchhof MG; Popradi P; Gniadecki R; Lynde C; Litvinov IV
Skin Therapy Lett; 2022 Sep; 27(5):1-6. PubMed ID: 36469458
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis: past, present, and future.
Knobler R; Barr ML; Couriel DR; Ferrara JL; French LE; Jaksch P; Reinisch W; Rook AH; Schwarz T; Greinix H
J Am Acad Dermatol; 2009 Oct; 61(4):652-65. PubMed ID: 19665258
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
[TBL] [Abstract][Full Text] [Related]
9. Photopheresis in the treatment of cutaneous T-cell lymphoma: current status.
Zic JA
Curr Opin Oncol; 2012 Jan; 24 Suppl 1():S1-10. PubMed ID: 22157241
[TBL] [Abstract][Full Text] [Related]
10. [Documented effect of extra corporeal photopheresis on T-cell mediated diseases].
Kofoed K; Schiødt I; Gniadecki R
Ugeskr Laeger; 2011 Jun; 173(26):1869-74. PubMed ID: 21712008
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photopheresis: Focus on therapeutic immunomodulation.
Couriel DR
Transfus Apher Sci; 2015 Apr; 52(2):149-50. PubMed ID: 25747959
[No Abstract] [Full Text] [Related]
12. Extracorporeal photopheresis: technique, established and novel indications.
Marques MB; Adamski J
J Clin Apher; 2014 Aug; 29(4):228-34. PubMed ID: 24828404
[TBL] [Abstract][Full Text] [Related]
13. [Apheresis in dermatologic diseases].
Strangi RM; D'Ascenzo G; Bilenchi R; Trovato E; Sansica P; Gorgoglione V
G Ital Nefrol; 2012; 29 Suppl 54():S119-24. PubMed ID: 22388842
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
15. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
[TBL] [Abstract][Full Text] [Related]
16. Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
Exp Toxicol Pathol; 1998 Sep; 50(4-6):397-401. PubMed ID: 9784014
[TBL] [Abstract][Full Text] [Related]
17. A concise review on extracorporeal photochemotherapy: Where we began and where we are now and where are we going!
Perotti C; Sniecinski I
Transfus Apher Sci; 2015 Jun; 52(3):360-8. PubMed ID: 25910538
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis in patients with refractory bronchiolitis obliterans developing after allo-SCT.
Lucid CE; Savani BN; Engelhardt BG; Shah P; Clifton C; Greenhut SL; Vaughan LA; Kassim A; Schuening F; Jagasia M
Bone Marrow Transplant; 2011 Mar; 46(3):426-9. PubMed ID: 20581885
[TBL] [Abstract][Full Text] [Related]
19. Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease.
Greinix HT; Worel N; Knobler R
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1747-8; author reply 1749. PubMed ID: 20601039
[No Abstract] [Full Text] [Related]
20. Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD).
Rutella S; Valentini CG; Ceccarelli S; Romano MT; Brescia LP; Milano GM; Locatelli F
Transfus Apher Sci; 2014 Jun; 50(3):340-8. PubMed ID: 24780391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
